U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07201233) titled 'Clinical Study on the Safety and Efficacy of Umbilical Cord Blood Infusion in Treating Bone Marrow Suppression .' on Sept. 19.
Brief Summary: The clinical study aims to evaluate the safety and efficacy of umbilical cord blood transfusion in treating bone marrow suppression after chemotherapy in elderly patients with MDS and AML
Study Start Date: Nov. 01
Study Type: INTERVENTIONAL
Condition:
Bone Marrow Suppression
Intervention:
BIOLOGICAL: Umbilical cord blood
Umbilical cord blood transfusion should be performed 24 hours to 2 weeks after chemotherapy. One to multiple units of cord blood can be applied, and the minimum interval...